Abstract
Takayasu arteritis (TAK) affects the aorta and its primary branches, mainly in young women. In its advanced stages, it can cause severe complications, such as cerebral infarction, impaired vision, and valvular heart diseases. In the aortic tissue of TAK, there is increased infiltration of cytotoxic lymphocytes, such as natural killer (NK) cells and CD8+T cells, and enhanced expression of accessory molecules, such as major histocompatibility complex (MHC) and MHC class I chain-related gene (MIC) family. Genome-wide association studies on TAK have identified susceptibility genes, such as IL-12p40, MICA, MICB, leukocyte immunoglobulin-like receptor A3 (LILRA3), and LILRB3. Other studies have also shown their involvement in the pathophysiology of TAK. In addition, we reported the importance of NK cells by enhancer enrichment analysis. These results suggest that the gene polymorphisms that potentially upregulate the expression of cytokines and accessory molecules, which contribute to the activation of cytotoxic lymphocytes, are associated with the development of TAK. Based on these results, new molecular targeted therapies look promising.
References
Oct 1, 1978·Tissue Antigens·I IsohisaT Sasazuki
Feb 1, 1994·The Journal of Clinical Investigation·Y SekoY Tada
Jan 31, 2004·Journal of Vascular Research·Yoshinori SekoRyozo Nagai
Apr 7, 2010·PLoS Genetics·Dan L NicolaeNancy J Cox
Jul 9, 2013·American Journal of Human Genetics·Chikashi TeraoFumihiko Matsuda
Jul 9, 2013·American Journal of Human Genetics·Güher Saruhan-DireskeneliAmr H Sawalha
Jan 22, 2015·Arthritis & Rheumatology·Paul A RenauerAmr H Sawalha
Mar 19, 2015·Heart and Vessels·Takayoshi MatsumuraMitsuaki Isobe
Aug 28, 2015·Scandinavian Journal of Rheumatology·C TeraoT Mimori
Oct 24, 2015·Journal of Autoimmunity·Amr H Sawalha, Mikhail G Dozmorov
May 6, 2016·Frontiers in Immunology·Marc ClementKarim Sacre
May 20, 2017·Arthritis Research & Therapy·Birgir GudbrandssonØyvind Palm
Sep 7, 2017·Arthritis Research & Therapy·Toshiki NakajimaTsuneyo Mimori
Dec 2, 2017·Annals of the Rheumatic Diseases·Yoshikazu NakaokaNorihiro Nishimoto
Nov 15, 2018·Modern Rheumatology·Hajime Yoshifuji
Dec 1, 2018·Proceedings of the National Academy of Sciences of the United States of America·Chikashi TeraoFumihiko Matsuda
Jan 21, 2020·Circulation Journal : Official Journal of the Japanese Circulation Society·Mitsuaki IsobeUNKNOWN JCS Joint Working Group
Mar 11, 2020·Nature Communications·Tomoyuki MutohHiroshi Fujii
Citations
Feb 20, 2021·Rheumatology Advances in Practice·Sebastian-Jonas SaurJörg Henes
May 1, 2021·Antibody Therapeutics·Mi DengCheng Cheng Zhang
Jun 18, 2021·International Journal of Rheumatic Diseases·Masahiro KondoMayuko Moriyama
Sep 25, 2021·Inflammation and Regeneration·Yoshiya Tanaka
Jul 3, 2021·Scientific Reports·Keiichiro KadobaHajime Yoshifuji